Discover a study that has revealed a new potential mechanism of understanding inflammation in ulcerative colitis.

The European Commission (EC) has approved a Marketing Authorization (MA) for Tremfya (guselkumab) to treat adults with ...

Recent years have seen significant advancements in UC treatment, offering renewed hope for patients seeking effective and ...

Research shows that smoking may have beneficial effects on symptoms of ulcerative colitis. But the risks of starting this ...

Guselkumab significantly improves clinical remission rates in patients with active ulcerative colitis, according to phase 3 data.

Hunter Renfrow is mounting an NFL comeback after spending the 2024 season out of the league battling ulcerative colitis. Here ...

Johnson & Johnson (J&J) has shared positive long-term results from a phase 3 trial of its dual-acting IL-23 inhibitor Tremfya ...

DelveInsight’s “Ulcerative Colitis Market Insights, Epidemiology and Market Forecast – 2034” report delivers an in-depth ...

Talk to your doctor about whether you meet the criteria. What is the main cause of ulcerative colitis? The exact cause of ulcerative colitis is unknown, but it is believed to involve a combination ...

Wide receiver Hunter Renfrow dropped from 185 pounds to 150 pounds at one point last year in his battle with ulcerative ...